Fundamentals

Valuation

Metric	Q4	Q2	Δ in %
EV/EBITDA	-98.12	59.59	-3172.54
Graham Fair Price	722.64	0.69	0.08
PEG	100.00	< 0.005	0.00
Price/Book	26.90	155.07	122.20
Price/Cash Flow	97.22	-836.68	-30101.27
Prices/Earnings	-98.12	14.90	-794.56
Price/Sales	0.00	0.00	0.00
Price/FCF	97.22	-836.68	-30101.27
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q2	Δ in %
Gross Profit Margin	0.00	0.00	0.00
Operating Margin	0.00	0.00	0.00
ROA	6681.94	0.03	< 0.005
ROE	-0.04	2.60	6667.38
ROIC	< 0.005	< 0.005	-518.52
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q2	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	-5.20	-100.00
EPS QOQ	0.00	81.00	100.00
FCF QOQ	0.00	-44.66	-100.00
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.00	0.00	0.00
Quick Ratio	4570.21	197.31	-95.68
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q2	Δ in %
Book Value	0.09	0.09	< 0.005
Cash	8.02	8.00	-0.20
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	-0.02	-4465.58
Revenue	0.00	0.00	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q2	Δ in %
Current Ratio	14.12	0.18	-98.75
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.69	-0.01	-99.77
Naive Interpretation	Member

06 - Financial Health · Bad

Rating